Company Data
Cingulate Inc.
Ticker
CING
Current Price
$4.03 11.94%
Market Cap
$54.3M
Price Target
Refer to Report
Volume
4.5M
52wk Range
$3.16 - $11.89
Overview
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.